Crohn’s disease following rituximab treatment in a patient with refractory nephrotic syndrome

Rituximab (RTX) is increasingly used for the treatment of refractory nephrotic syndrome due to its inhibitory effect on B cells which extends the period of remission, while lowering the dose of steroids needed for disease management. However, RTX can lead to various side effects, including Crohn’s d...

Full description

Saved in:
Bibliographic Details
Published in:CEN Case Rep
Main Authors: Morita, Keishi, Shibano, Takayuki, Maekawa, Kohei, Hattori, Masuji, Hida, Nobuyuki, Nakamura, Shiro, Takeshima, Yasuhiro
Format: Artigo
Language:Inglês
Published: Springer Singapore 2018
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6361080/
https://ncbi.nlm.nih.gov/pubmed/30251194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-018-0364-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items